1. Canada Stocks

  2. •

    Health technology

  3. •

    Medical specialties
DataMetrex AI Ltd.

DataMetrex AI Ltd.

0.05
CAD
+0.00
(-10.00%)
-0.18EPS
6.87MMarket Cap
Nov 26Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2025 Y
2026 Y
TTM
Revenue per Share
- -
- -
- -
- -
0.09
0.34
0.46
1.46
4.55
2.36
0.64
0.34
0.11
0.11
Basic EPS, GAAP
-0.54
-0.22
-0.1
-0.09
-2.15
-2.92
-0.37
-0.59
0.84
-1.34
-1.02
-0.16
-0.18
-0.18
Free Cash Flow per Basic Share
-0.63
-0.14
-0.24
-0.1
-1.7
-0.84
-0.16
-0.07
1.06
-0.18
-0.59
-0.08
-0.05
-0.05
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
0.85
0.7
0.6
0.51
1.65
0.65
0.37
0.36
2.74
1.66
0.76
0.03
-0.01
-0.01
Tangible Book Value per Share
0.85
0.7
0.6
0.51
0.31
-0.34
-0.39
-0.23
1.18
0.66
-0.18
0.03
-0.01
-0.01
Basic Weighted Avg Shares
- -
- -
- -
- -
2
7
7
8
11
13
13
19
69
70
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
2
3
12
49
30
9
6
7
7
Operating Margin (%)
- -
- -
- -
- -
-1,538.95
-280.21
-94.56
-34.41
22.44
-7.87
-133.7
-35.38
-41.92
-41.92
Depreciation Expense
- -
- -
- -
- -
- -
3
1
1
2
3
3
1
1
1
Net Income, GAAP
- -
- -
- -
- -
-5
-19
-3
-5
9
-17
-14
-3
-13
-13
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
22.74
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
-2,332.85
-869.81
-81.83
-40.44
18.54
-56.61
-159.28
-47.2
-169.23
-169.23
Working Capital
- -
- -
- -
- -
3
-3
-4
-2
14
6
-5
- -
-2
-2
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
4
3
1
2
2
Total Equity
- -
- -
- -
- -
9
4
3
3
32
23
10
1
-1
-1
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
41.59
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
49.81
- -
- -
- -
- -
- -
Return on Common Equity (%)
-40.31
-27.87
-15.41
-16.87
-115.42
-289.72
-76.51
-162.74
50.87
-62.47
-81.99
-55.75
- -
- -

Capital Structure

CAD

•

in mil. unless spec.
Sep'26
Dec'26
Mar'26
ST Debt
2
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
3
2
2
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
32
153
153
Market Capitalization
3
13
7

Working Capital

CAD

•

in mil. unless spec.
Sep'26
Dec'26
Mar'26
Total Current Assets
4
6
2
Cash, Cash Equivalents & STI
- -
2
1
Accounts Receivable, Net
2
3
1
Inventories
- -
- -
- -
Total Current Liabilities
5
3
4
Payables & Accruals
3
3
3
ST Debt
2
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

CAD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
491.51%
91.89%
-263.15%
Free Cash Flow
907.06%
-363.86%
105.85%
Net Income, GAAP
1,466.05%
-71.44%
313.03%
Sales/Revenue/Turnover
- -
35.52%
15.2%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

CAD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
1
2
2
- -
6
2026
1
1
3
2
7

Quarterly Earnings Per Share

CAD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
-0.08
-0.02
0.09
-0.15
-0.16
2026
-0.03
-0.02
-0.02
-0.06
-0.18

Quarterly Dividends Per Share

CAD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Michael Kron
Full Time Employees
21
Sector
Health technology
Industry
Medical specialties
Address
90 Eglinton Ave E Toronto ON Canada M4P 2Y3
IPO Date
Jun 12, 2017
Website
datametrex.com
Similar Companies
Intuitive Surgical, Inc. (NASDAQ:ISRG)
Boston Scientific Corporation (NYSE:BSX)
Thermo Fisher Scientific Inc (NYSE:TMO)
Illumina, Inc. (NASDAQ:ILMN)
Abbott Laboratories (NYSE:ABT)
GRAIL, Inc. (NASDAQ:GRAL)
Business
Datametrex AI Limited is a technology company specializing in artificial intelligence, machine learning, and big data analytics; it collects, analyzes, and presents structured and unstructured data for government and corporate clients through platforms such as dataTap and dashboard systems. The company offers core products and services including AnalyticsGPT, an AI and machine learning platform for actionable insights; cybersecurity solutions via Nexalogy's NexaSecurity social media discovery and monitoring platform and NexaSMART; health security businesses encompassing telemedicine through Medi-call for iOS and Android devices, concierge medical services, Imagine Health multidisciplinary healthcare centers with walk-in services, pharmacies, and ancillary offerings in Calgary and Edmonton; EV charging solutions such as mobile charging services, Mobile EV chargers, and AC EV chargers; and IT services including big data analysis, system integration, and hardware sales primarily in South Korea. Founded in 2011 and headquartered at 2300 Yonge Street, Suite 2802 in Toronto, Ontario, Datametrex operates through AI & Technology and Health Care segments with geographic presence in Canada, South Korea, and offices in Vancouver, Seoul, Berlin, and Montreal; its wholly-owned subsidiary Nexalogy provides advanced AI tools for social media research, including patented natural language processing and text analytics software used by Canadian and U.S. armed forces. Recent developments include securing approximately CAD $650,000 in purchase orders through Datametrex Korea in November 2025, reflecting its land-and-expand strategy with clients in services, finance, and public sectors; closing a CAD $5.13 million financing in November 2025 via 47.9 million common shares and 16.25 million subscription receipts to support growth and a proposed acquisition pending TSX Venture Exchange approval; launching new walk-in services and welcoming new physicians at Imagine Health clinics in Calgary and Edmonton in 2025; and reporting CAD $1.3 million in AI and tech revenue from Korean IT services in the first half of 2024 with a 37% gross profit margin.

Company News

Company News APIChatGPT

  • accessnewswire.com

    DataMetrex Signs Definitive Agreement to Acquire Yuzu Payment Processing Solution From Firstpayment Inc.

  • accessnewswire.com

    Datametrex Announces New Walk-In Services at Imagine Health Calgary and Edmonton Clinics